Home  >  Products  >  PRMT2 (protein arginine methyltransferase 2) Blocking Peptide (the N terminal of protein) (100ug)
PRMT2 (protein arginine methyltransferase 2) Blocking Peptide (the N terminal of protein) (100ug)

PRMT2 (protein arginine methyltransferase 2) Blocking Peptide (the N terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PRMT2 antibody (Catalogue #: ARP40195_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40195
Size: 100 ug
Weight: 49kDa
Gene: 3275
Format: Lyophilized powder
Target: The protein arginine methyltransferases (PRMTs) include a family of proteins with related putative methyltransferase domains that modify chromatin and regulate cellular transcription. PRMT2 inhibits NF-kappaB-dependent transcription and promotes apoptosis and it exerts this effect by blocking nuclear export of IkappaB-alpha through a leptomycin-sensitive pathway, increasing nuclear IkappaB-alpha and decreasing NF-kappaB DNA binding. PRMT2 also rendered cells susceptible to apoptosis by cytokines or cytotoxic drugs, likely due to its effects on NF-kappaB.
Alternative names: HRMT1L1; MGC111373